Catalyst Wire Dossier Catalyst Wire Dossier

rapid-acting mealtime insulin

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for rapid-acting mealtime insulin, covering 2021-09-30 to 2021-09-30. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Rapid-Acting Mealtime Insulin in Children and Adolescents With Newly Diagnosed Type 1 Diabetes Mellitus [Phase 4]

See pricing